Document is current

Article History

Received: 14 August 2025

Accepted: 29 October 2025

First Online: 12 December 2025

Declarations

:

: We the undersigned declare that this manuscript entitled “Tumor Immune Microenvironment Score Predicts Efficacy of Immune Checkpoint Inhibitors-Based Regimens in Advanced Non-Small Cell Lung Cancer” is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us.We understand that the Corresponding Author is the sole contact for the Editorial process. He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.

: J.W., X.L., P.C., and C.Z. are employed by Amoy Diagnostics. The other authors declare no competing interests.